Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05572658 · ClinicalTrials.gov registry record
Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study
A clinical trial, sponsored by ModernaTX.
- Completed
- Registry status
- 10,994
- Enrollment target
NCT05572658 is a clinical trial that has completed, run by ModernaTX. The registered enrollment target is 10,994 participants.
The verdict
NCT05572658 has completed, sponsored by ModernaTX.
- COMPLETED
- Registry status
- 10,994 participants
- Enrollment target
Study Summary
The main goal of this observational study is to describe the health and economic outcomes associated with use of the Moderna mRNA-1345 vaccine.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL mRNA-1345
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,994 participants |
| Start Date | 2022-09-15 |
| Est. Completion | 2023-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05572658
The ClinicalTrials.gov registry entry for NCT05572658 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,994 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ModernaTX, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05572658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05572658 about?
NCT05572658 is a clinical study titled "Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study". The main goal of this observational study is to describe the health and economic outcomes associated with use of the Moderna mRNA-1345 vaccine.
What is the current status of trial NCT05572658?
This trial is currently completed. The enrollment target is 10,994 participants. The study started on 2022-09-15. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT05572658?
The interventions under investigation include: Placebo (BIOLOGICAL), mRNA-1345 (BIOLOGICAL).
Who is sponsoring clinical trial NCT05572658?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.